Neuraxpharm CEO Confirms Expansion Into New Markets, Including US

Company’s Value-Added Segment Expected To Soon Account For Half Of Sales

Neuraxpharm CEO
Neuraxpharm’s Dierks talks about international expansion and becoming a European leader in Medical Cannabis • Source: Neuraxpharm

More from Strategy

More from Business